The Medical Device Manufacturers Association and the Alliance of U.S. Startups and Inventors for Jobs sent a letter today to the leadership of the Senate Judiciary Committee and the Subcommittee on Intellectual Property to express their support for both the PREVAIL Act and the Patent Eligibility Restoration Act.
Efforts by high-tech companies to undermine both the Patent Eligibility Restoration Act of 2023 and the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act ramped up this week.
The America Invents Act of 2011 was designed to provide a durable overhaul of the U.S. patent system, but the inter partes review (IPR) process has drawn fire from inventors as a patent-killing machine. The Senate is considering a new bill to address some of these concerns, but witnesses at a hearing this week were anything but united in their assessment of the status quo, making it difficult to forecast the fate of this latest effort at patent reform.
How a Broken Patent System Contributes to Unaffordable Prescription Drugs rstreet.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rstreet.org Daily Mail and Mail on Sunday newspapers.